Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Quest Diagnostics Incorporated

DGX
Current price
156.36 USD +1.02 USD (+0.66%)
Last closed 154.38 USD
ISIN US74834L1008
Sector Healthcare
Industry Diagnostics & Research
Exchange NYSE
Capitalization 17 185 118 208 USD
Yield for 12 month +24.30 %
1Y
3Y
5Y
10Y
15Y
DGX
21.11.2021 - 28.11.2021

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey. Address: 500 Plaza Drive, Secaucus, NJ, United States, 07094

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

155.05 USD

P/E ratio

20.834

Dividend Yield

1.94 %

Current Year

+9 252 000 000 USD

Last Year

+9 883 000 000 USD

Current Quarter

+2 397 000 000 USD

Last Quarter

+2 366 000 000 USD

Current Year

+3 053 000 000 USD

Last Year

+3 433 000 000 USD

Current Quarter

+776 000 000 USD

Last Quarter

+755 000 000 USD

Key Figures DGX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 1 791 000 064 USD
Operating Margin TTM 15.52 %
PE Ratio 20.834
Return On Assets TTM 6.13 %
PEG Ratio 1.6015
Return On Equity TTM 13.59 %
Wall Street Target Price 155.05 USD
Revenue TTM 9 345 999 872 USD
Book Value 59.61 USD
Revenue Per Share TTM
Dividend Share 2.92 USD
Quarterly Revenue Growth YOY 2.5 %
Dividend Yield 1.94 %
Gross Profit TTM 3 467 000 000 USD
Earnings per share 7.41 USD
Diluted Eps TTM 7.41 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY -1 %
Profit Margin 8.99 %

Dividend Analytics DGX

Dividend growth over 5 years

43 %

Continuous growth

Payout Ratio 5 years average

37 %

Dividend History DGX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 3
Ex Dividend Date 04.10.2024
Forward Annual Dividend Yield 1.94 %
Last Split Factor 2:1
Payout Ratio 33.79 %
Last Split Date 21.06.2005
Dividend Date 21.10.2024

Stock Valuation DGX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 20.834
Forward PE 16.0256
Enterprise Value Revenue 2.3542
Price Sales TTM 1.8388
Enterprise Value EBITDA 12.5583
Price Book MRQ 2.5971

Financials DGX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators DGX

For 52 weeks

116.97 USD 159.36 USD
50 Day MA 148.88 USD
Shares Short Prior Month 2 334 377
200 Day MA 137.71 USD
Short Ratio 3.38
Shares Short 2 554 118
Short Percent 2.62 %